Will investments in biobanks, prospective cohorts, and markers of common patterns of variation benefit other populations for drug response and disease susceptibility gene discovery?

Morris W. Foster, Richard R Sharp

Research output: Contribution to journalArticle

4 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)75-80
Number of pages6
JournalPharmacogenomics Journal
Volume5
Issue number2
DOIs
StatePublished - 2005
Externally publishedYes

Fingerprint

Genetic Databases
Drug Design
Disease Susceptibility
Genetic Association Studies
Genetic Predisposition to Disease
Genetic Markers
Cohort Studies
Prospective Studies
Phenotype
Pharmaceutical Preparations
Population

ASJC Scopus subject areas

  • Pharmacology
  • Molecular Medicine
  • Genetics

Cite this

@article{48c01c7865fb47d79f8767d2630994c9,
title = "Will investments in biobanks, prospective cohorts, and markers of common patterns of variation benefit other populations for drug response and disease susceptibility gene discovery?",
author = "Foster, {Morris W.} and Sharp, {Richard R}",
year = "2005",
doi = "10.1038/sj.tpj.6500295",
language = "English (US)",
volume = "5",
pages = "75--80",
journal = "Pharmacogenomics Journal",
issn = "1470-269X",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Will investments in biobanks, prospective cohorts, and markers of common patterns of variation benefit other populations for drug response and disease susceptibility gene discovery?

AU - Foster, Morris W.

AU - Sharp, Richard R

PY - 2005

Y1 - 2005

UR - http://www.scopus.com/inward/record.url?scp=16344382361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16344382361&partnerID=8YFLogxK

U2 - 10.1038/sj.tpj.6500295

DO - 10.1038/sj.tpj.6500295

M3 - Article

C2 - 15668730

AN - SCOPUS:16344382361

VL - 5

SP - 75

EP - 80

JO - Pharmacogenomics Journal

JF - Pharmacogenomics Journal

SN - 1470-269X

IS - 2

ER -